| Non-genomic and immune evolution of melanoma acquiring MAPKi resistance W Hugo, H Shi, LU Sun, M Piva, C Song, X Kong, G Moriceau, A Hong, ... Cell 162 (6), 1271-1285, 2015 | 644 | 2015 |
| Sox2 promotes tamoxifen resistance in breast cancer cells M Piva, G Domenici, O Iriondo, M Rábano, BM Simões, V Comaills, ... EMBO molecular medicine 6 (1), 66-79, 2014 | 353 | 2014 |
| mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer A Zabala-Letona, A Arruabarrena-Aristorena, N Martín-Martín, ... Nature 547 (7661), 109-113, 2017 | 206 | 2017 |
| Recurrent tumor cell–intrinsic and–extrinsic alterations during MAPKi-induced melanoma regression and early adaptation C Song, M Piva, LU Sun, A Hong, G Moriceau, X Kong, H Zhang, S Lomeli, ... Cancer discovery 7 (11), 1248-1265, 2017 | 158 | 2017 |
| Effects of estrogen on the proportion of stem cells in the breast BM Simões, M Piva, O Iriondo, V Comaills, JA López-Ruiz, I Zabalza, ... Breast cancer research and treatment 129, 23-35, 2011 | 149 | 2011 |
| Exploiting drug addiction mechanisms to select against MAPKi-resistant melanoma A Hong, G Moriceau, L Sun, S Lomeli, M Piva, R Damoiseaux, SL Holmen, ... Cancer discovery 8 (1), 74-93, 2018 | 114 | 2018 |
| Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy Y Wang, S Liu, Z Yang, AP Algazi, SH Lomeli, Y Wang, M Othus, A Hong, ... Cancer Cell 39 (10), 1375-1387. e6, 2021 | 102 | 2021 |
| Stratification and therapeutic potential of PML in metastatic breast cancer N Martín-Martín, M Piva, J Urosevic, P Aldaz, JD Sutherland, ... Nature communications 7 (1), 12595, 2016 | 60 | 2016 |
| Durable suppression of acquired MEK inhibitor resistance in cancer by sequestering MEK from ERK and promoting antitumor T-cell immunity A Hong, M Piva, S Liu, W Hugo, SH Lomeli, V Zoete, CE Randolph, ... Cancer discovery 11 (3), 714-735, 2021 | 59 | 2021 |
| Acquired resistance of ER-positive breast cancer to endocrine treatment confers an adaptive sensitivity to TRAIL through posttranslational downregulation of c-FLIP L Piggott, A Silva, T Robinson, A Santiago-Gómez, BM Simões, M Becker, ... Clinical Cancer Research 24 (10), 2452-2463, 2018 | 51 | 2018 |
| High-speed live-cell interferometry: a new method for quantifying tumor drug resistance and heterogeneity D Huang, KA Leslie, D Guest, O Yeshcheulova, IJ Roy, M Piva, ... Analytical chemistry 90 (5), 3299-3306, 2018 | 47 | 2018 |
| Targeting PML in triple negative breast cancer elicits growth suppression and senescence L Arreal, M Piva, S Fernández, A Revandkar, A Schaub-Clerigué, ... Cell Death & Differentiation 27 (4), 1186-1199, 2020 | 42 | 2020 |
| Recurrent tumor cell-intrinsic and-extrinsic alterations during MAPKi-induced melanoma regression and early adaptation. Cancer Discov. 2017; 7: 1248–1265. doi: 10.1158/2159-8290 C Song, M Piva, L Sun, A Hong, G Moriceau, X Kong, H Zhang, S Lomeli, ... CD-17-0401.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 29 | |
| Enhancing PD-L1 degradation by ITCH during MAPK inhibitor therapy suppresses acquired resistance Z Yang, Y Wang, S Liu, W Deng, SH Lomeli, G Moriceau, J Wohlschlegel, ... Cancer discovery 12 (8), 1942-1959, 2022 | 28 | 2022 |
| PPARδ elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth N Martín-Martín, A Zabala-Letona, S Fernández-Ruiz, L Arreal, ... Cancer Research 78 (2), 399-409, 2018 | 26 | 2018 |
| Human mammospheres secrete hormone-regulated active extracellular vesicles E Gonzalez, M Piva, E Rodriguez-Suarez, D Gil, F Royo, F Elortza, ... PLoS One 9 (1), e83955, 2014 | 16 | 2014 |
| Vivanco Md M Piva, G Domenici, O Iriondo, M Rábano, BM Simões, V Comaills, ... Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Mol Med 6 (1 …, 2014 | 13 | 2014 |
| Correction: Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer A Zabala-Letona, A Arruabarrena-Aristorena, N Martín-Martín, ... Nature 554 (7693), 554-554, 2018 | 10 | 2018 |
| Respuesta hormonal de las células madre de mama y resistencia a tamoxifeno G Domenici, M Rábano, M Piva, O Iriondo, I Zabalza, JA López-Ruiz, ... Revista de Senología y Patología Mamaria 27 (4), 149-156, 2014 | 7 | 2014 |
| Rá bano M Piva, G Domenici, O Iriondo M., Simoes, BM, Comaills, V., Barredo, I., Ló pez-Ruiz, JA, Zabalza, I …, 2014 | 5 | 2014 |
